Thomas Patrick Kelly
Chief Financial Officer · 2 filings · Latest: Oct 15, 2026
Xenon Pharmaceuticals Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
XENE | Thomas Patrick Kelly | Chief Financial Officer | Oct 15, 2026 | Option Exercise | — | 7,500 | — | 22,500 | |
XENE | Thomas Patrick Kelly | Chief Financial Officer | Sep 30, 2026 | Purchase | $37.32 | 15,000 | $559.7K | 15,000 | |